Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT

NCT07720232 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Hypertriglyceridemic Acute Pancreatitis
Acute Pancreatitis, Hypertriglyceridemia-induced
Hyperlipidemia

Interventions

DRUG: Live Combined Bacillus subtilis and Enterococcus faecium Enteric-coated Capsules (LCBE)
DRUG: Standard Care (in control arm)

Sponsor

Jianyin Zhou